Ken Griffin Tiziana Life Sciences LTD Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 19,200 shares of TLSA stock, worth $17,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,200Holding current value
$17,088% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
31Shares Held
1.03MCall Options Held
19.2KPut Options Held
0-
Geode Capital Management, LLC Boston, MA219KShares$194,6260.0% of portfolio
-
Hsbc Holdings PLC London, X0115KShares$102,6740.0% of portfolio
-
Morgan Stanley New York, NY110KShares$97,6740.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$70,6340.0% of portfolio
-
Zhang Financial LLC69.4KShares$61,7540.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $91M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...